Physician profile
Mariann Simpson
NPI 1245213883
$4,324.34
in general payments reported to CMS, 2019-2025
36 companies · $922 in 2025
The $922 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $624 · 2022: $725 · 2023: $977 · 2024: $1,076 · 2025: $922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,779 · Education: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,779.08 |
| Education | $196.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $717.48 | 2021-2025 | |
| Astellas Pharma US INC | $444.00 | 2021-2025 | Veozah, Myrbetriq |
| Lilly USA, LLC | $422.01 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $404.55 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $362.68 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $322.75 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $227.43 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Janssen Pharmaceuticals, INC | $123.06 | 2024-2025 | Spravato |
| Medtronic, INC. | $114.19 | 2024-2025 | Interstim, Intellis Adaptivestim |
| Takeda Pharmaceuticals U.S.A., INC. | $108.55 | 2021-2022 | |
| Teleflex LLC | $106.57 | 2024 | Urolift |
| Abbott Laboratories | $103.14 | 2023-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Exact Sciences Corporation | $97.18 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.83 | 2021-2024 | Ofev |
| Amgen INC. | $73.29 | 2023-2025 | Evenity, Prolia, Otezla |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariann Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.